SCPH - Cash Flow Statement - scPharmaceuticals Inc.

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017	Dec-2016	Dec-2015
OPERATING CASH FLOW
Net Income	(85.1)	(54.8)	(36.8)	(28.0)	(32.2)	(33.0)	(29.4)	(23.8)	(24.4)	(10.5)
Depreciation & Amortization	20 K	0.6	0.5	0.4	0.4	0.4	0.3	0.2	5 K	4 K
Deferred Income Tax	0	0	0	0	30 K	2 K	0	0	0	0
Stock Based Compensation	5.4	4.9	2.8	2.4	2.0	1.4	2.1	0.9	0.9	0.4
Other Operating Activities	9.1	(3.6)	(0.7)	0.7	0.6	0.4	0.4	0.2	6.5	(0.4)
Change in Working Capital	0	(6.3)	(0.3)	(2.6)	1.4	0.4	(2.2)	(0.2)	1.5	0.9
Cash From Operations	(70.5)	(59.2)	(34.6)	(27.2)	(27.7)	(30.4)	(28.8)	(22.7)	(15.5)	(9.6)
INVESTING CASH FLOW
Capital Expenditures	21 K	40 K	21 K	9 K	0	0	0	(0.2)	9 K	17 K
Other Items	29.3	20.0	(45.8)	32.1	(33.5)	0	0	0	0	0
Cash From Investing Activities	29.3	20.0	(45.9)	32.1	(33.5)	0	0	(0.2)	9 K	17 K
FINANCING CASH FLOW
Common Stock Repurchased	0	0	0	81 K	(0.2)	0	4 K	3 K	0	9 K
Total Debt Repaid	(3.2)	0	29.8	(2.5)	0	9.6	62 K	9.3	12.6	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Other Financing Activities	19.8	0.8	(0.3)	81 K	(0.2)	60 K	58 K	94 K	40.6	8.0
Cash From Financing Activities	70.1	14.8	77.2	(2.5)	60.3	13.6	8 K	102.1	53.2	8.0
CHANGE IN CASH
Net Change In Cash	28.8	(24.4)	(3.2)	2.4	(0.8)	(16.9)	(28.8)	79.2	37.7	(1.6)
FREE CASH FLOW
Free Cash Flow	(70.6)	(59.3)	(34.6)	(27.2)	(27.7)	(30.4)	(28.8)	(22.9)	(15.5)	(9.7)

Free